News & Updates
Filter by Specialty:
FLT3 inhibitor improves survival in patients with FLT3+ acute myeloid leukaemia
Patients diagnosed with acute myeloid leukaemia with an FLT3 mutation (FLT3+ AML) may benefit from the addition of an FLT3 inhibitor to intensive chemotherapy postinduction by improving event-free (EFS) or overall survival (OS), suggests a study.
FLT3 inhibitor improves survival in patients with FLT3+ acute myeloid leukaemia
23 Aug 2022
Patient decision aid helps in decision-making process when selecting regimen for CRC
A newly developed patient decision aid (PDA) aids in the shared decision-making in choosing first-line targeted therapy for metastatic colorectal cancer (CRC), reports a study in Taiwan.
Patient decision aid helps in decision-making process when selecting regimen for CRC
22 Aug 2022
Which factors predict relapse after antiviral therapy cessation in paediatric CHB?
Nearly one in three children with chronic hepatitis B (CHB) who discontinued their antiviral treatment has relapsed, a study has shown.
Which factors predict relapse after antiviral therapy cessation in paediatric CHB?
19 Aug 2022
Add-on dupilumab reduces OCS use in patients with steroid-dependent severe asthma
In patients with chronic dependence on oral corticosteroids (OCS) for severe asthma, long-term exposure to dupilumab supports sustained reduction in OCS dosage and improvement in clinical outcomes for up to 96 weeks, according to an analysis of the phase III LIBERTY ASTHMA TRAVERSE study.